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Abstract
Background: Scleroderma is a chronic connective tissue disorder with unknown etiology. It is characterized by
excessive deposition of extracellular matrix in the connective tissues causing vascular disturbances which can result
in tissue hypoxia. These changes are manifested as atrophy of the skin and/or mucosa, subcutaneous tissue,
muscles, and internal organs. Such changes can be classified into two types, namely, morphea (localized)
and diffuse (systemic). Morphea can manifest itself as hemifacial atrophy (Parry–Romberg syndrome) although this
remains debatable. Hence, we present a case of morphea, associated with Parry–Romberg syndrome, and a second
case with the classical signs of progressive systemic sclerosis.
Case presentation: Case one: A 20-year-old man of Dravidian origin presented to our out-patient department with
a complaint of facial asymmetry, difficulty in speech, and loss of taste sensation over the last 2 years. There was no
history of facial trauma. After physical and radiological investigations, we found gross asymmetry of the left side
of his face, a scar on his chin, tongue atrophy, relative microdontia, thinning of the ramus/body of his mandible,
and sclerotic lesions on his trunk. Serological investigations were positive for antinuclear antibody for double-
stranded deoxyribonucleic acid and mitochondria. A biopsy was suggestive of morphea. Hence, our final
diagnosis was mixed morphea with Parry–Romberg syndrome.
Case two: A 53-year-old woman of Dravidian origin presented to our out-patient department with a complaint of
gradually decreasing mouth opening over the past 7 years. Her medical history was noncontributory. On clinical
examination, we found her perioral, neck, and hand skin to be sclerotic. Also, her fingers exhibited bilateral
telangiectasia. An oral examination revealed completely edentulous arches as well as xerostomia and candidiasis.
Her serological reports were positive for antinuclear antibodies against centromere B, Scl-70, and Ro-52. A hand
and wrist radiograph revealed acro-osteolysis of the middle finger on her right hand. Hence, our final diagnosis
was progressive systemic sclerosis.
Conclusion: Through this article, we have tried to emphasize the importance of a general examination when
diagnosing rare systemic diseases such as scleroderma and the role of the general dentist when caring for such
patients, even though they can be quite rare in general practice.
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Background
Scleroderma is a chronic sclerosing disease of the con-
nective tissues. It derives its name from the Greek words
scleros (hard) and derma (skin). Hidebound skin is an
important and characteristic feature of this disease
thereby making the name “hidebound disease” more
popular [1, 2]. The first description of this disease as a
separate pathological entity was given by Carlo Curzio of
Naples in 1752 [2, 3] and its first name, “sclerodermie,”
was given nearly a century later by Gintrac in 1847. For
years, the disease was thought to be a dermatological
disorder but after its distinctive characteristic of sys-
temic involvement was proven, Goetz coined the term
“progressive systemic sclerosis” in 1945 [2, 4].
Scleroderma exists in two forms: morphea (circum-
scribed scleroderma) and generalized/progressive (diffuse
scleroderma). However, some articles have mentioned
acrosclerosis (scleroderma of the peripheries associated
with Raynaud’s phenomenon) as a third form [5, 6]. Mor-
phea (localized scleroderma) is again subdivided into five
types, namely: plaque, generalized, bullous, linear, and
deep [7, 8]. CREST syndrome (calcinosis cutis, Raynaud’s
phenomenon, esophageal dysfunction, sclerodactyly, and
telangiectasia), a rare condition, is thought to be a hetero-
geneous variant of systemic scleroderma [9]. Similarly,
Parry–Romberg syndrome (hemifacial atrophy) is thought
to be another variant of scleroderma. However, this
remains debatable [8, 10, 11].
Scleroderma was described as a pathological entity in
the mid-eighteenth century but to date the exact
etiopathogenesis is still unknown, possibly because of
the disease’s rarity. However, it is understood that age,
gender, genetic, and environmental factors can influence
vulnerability for the disease [2]. Some authors have sug-
gested viral or bacterial infection (Borrelia burgdorferi),
particularly in the case of morphea, as the causative
agent. But sufficient evidence to support such claims is
lacking [8]. Untimely interaction of immunity with the
vascular system resulting in endothelial damage is also
hypothesized as a major contributor for the initiation
and progression of the disease [2, 12].
Systemic sclerosis (diffuse/generalized/progressive sclero-
derma) initially manifests itself as pitting edema of the skin
which progresses to a thickening and hardening of the skin.
The systemic form can involve multiple organs, such as
the kidneys, lungs, heart, and the gastrointestinal sys-
tem, among which the involvement of the latter is most
common. These organs are affected either by fibrosis or
by a diminished blood supply. Raynaud’s phenomenon
(paroxysmal vasospasm), claw-like fingers, hyperpigmenta-
tion, telangiectasia, and subcutaneous calcification are other
common systemic manifestations that can be seen. Oral
and facial tissues are the most affected, manifesting as the
characteristic mask-like face (Mona Lisa face), constricted
lips (fish mouth), a narrowing and stiffening of the tongue
(chicken tongue), microstomia, pseudoankylosis, resorption
of the mandibular angle, xerostomia, dental caries, and a
widening, radiographically, of periodontal ligaments [2, 13].
Oral ulceration, secondary to gastroesophageal reflux
disease (GERD), is also reported in some cases [6]. Most
of the time, as a result of these manifestations, patients
visit dentists for these aesthetical and facial dysfunctions.
Morphea (localized scleroderma), on the other hand,
causes localized fibrosis similar to scleroderma, resulting
in localized indurated lesions [14]. As mentioned earlier,
morphea can be subdivided into five different types.
Mixed forms, such as localized scleroderma of the face
with plaque/linear morphea at some other site, have
been reported in the literature [15].
The face is the most common site for the linear type
of morphea with fibrosed tissue appearing as a sabre cut
(en coup de sabre) resulting in facial hemiatrophy mim-
icking Parry–Romberg syndrome [2]. Hence, with this
article we are presenting two such cases of scleroderma
reporting to us with aesthetical and facial dysfunctions.
Both cases were later diagnosed as mixed morphea,




A 20-year-old man of Dravidian origin presented to our
Department of Oral Medicine and Radiology with the
chief complaint of facial asymmetry over the past 2 years.
According to him, and on review of photographs he had
brought, his facial symmetry was within normal limits
prior to these past 2 years. He also reported difficulty in
articulation and a loss of taste sensation. He also presented
with skin lesions on his trunk (abdomen and back).
His medical and family histories were noncontributory.
On general examination, he was found to be conscious
and oriented. His vital signs were within normal range.
He had limited, well-circumscribed, and oval-shaped hy-
perpigmented lesions on his abdomen and back (Fig. 1).
These lesions appeared fibrotic on palpation. A head
and neck examination revealed gross asymmetry of the
left side of his face and there was a sharp demarcation
on his chin, separating the normal and abnormal side
(Fig. 2).
A visually evident loss of fat, muscles, and subcutane-
ous tissue resulted in a shrunken appearance to the left
side of his face. His left ear pinna appeared to be
fibrosed on palpation. Skin on the affected side appeared
to be sclerotic. An ocular examination disclosed no ab-
normalities. An intraoral examination revealed shrunken
and rigid left side of his tongue otherwise his mucosa
appeared to be normally moist (Fig. 3). A hard tissue
examination offered no relevant findings.
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Hence, our provisional diagnosis was facial hemiatro-
phy with plaque morphea and further investigation was
recommended.
Panoramic view showed relative microdontia on the
left side, with a thinning of his mandibular body and
ramus (Fig. 4). Submentovertex and posteroanterior
views also revealed gross asymmetry of the left side of
his jaw. Serological investigations were positive for
double-stranded deoxyribonucleic acid (DNA) and
antimitochondrial antibody; however, his erythrocyte
sedimentation rate (ESR) levels were normal.
Fundoscopic examination of his eyes and audiometry
showed no abnormalities. Ultrasonography examinations
of his bilateral buccal mucosa and parotid glands were
normal. A skin biopsy revealed a thickened epidermis
with sparse adnexal structures. Thickened and closely
packed collagen bundles in reticular dermis, along with
hypocellularity and sparse lymphoplasmacytic infiltrate
in the dermis, were suggestive of morphea.
After correlating these findings with the available lit-
erature, the final diagnosis of mixed morphea with
Parry–Romberg syndrome was given.
Case two
A 53-year-old woman of Dravidian origin visited our
department complaining of difficulty in using her
complete dentures as a result of the gradual reduction in
mouth opening over the previous 7 years. She also com-
plained of a burning sensation of her oral mucosa (pre-
dominantly in her palate) and a tightness of the skin in
her perioral and neck regions. On clinical examination
Fig. 1 Morphea seen on trunk (back) of patient
Fig. 2 Gross asymmetry of face (left side) with “en coup de sabre”
on chin
Fig. 3 Atrophy of tongue (left side)
Fig. 4 Panoramic view showing gross asymmetry of face (left side)
with relative microdontia and thinning of ramus/body of mandible
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we found her face to be expressionless. On palpation,
the skin of her perioral and neck regions was sclerotic
(Fig. 5). The skin on her fingers also appeared to be pale
on inspection and indurated when palpated. According
to our patient, this paleness spreads symmetrically to all
ten fingers when exposed to cold, suggestive of Ray-
naud’s phenomenon. Her fingers also showed areas of
telangiectasia (Fig. 6). An oral examination revealed
completely edentulous maxillary and mandibular arches,
microstomia due to rigid perioral skin, xerostomia (positive
tongue blade test), and an erythematous patch on her
palate. The clinical findings were suggestive of progressive
systemic sclerosis; hence, we recommended radiological
and serological investigations. For the erythematous lesion,
a swab was taken and was sent for culture. These investiga-
tive reports were consistent with our provisional diagnosis.
The serological reports were positive for increased serum
C3 level and a ribonucleic acid (RNA) profile was positive
for centromere B, Scl-70, and Ro-52, explaining her inabil-
ity to use her prostheses with which she had been comfort-
able 7 years prior. In addition, a radiograph of her hand
and wrist revealed reabsorption of the terminal phalanges
(acro-osteolysis) of the middle finger on her right hand
(Fig. 7). A swab culture was positive for candidiasis, which
reflected alteration of her oral microflora secondary to
xerostomia, resulting in a burning sensation.
Discussion
Progressive/diffuse/generalized sclerosis is more common
in the fourth to sixth decades of life and it affects females
more than males with a 3 to 6:1 ratio, respectively [16].
The American College of Rheumatology has recom-
mended criteria for the diagnosis of systemic scleroderma
with the major criterion as proximal diffuse (truncal)
sclerosis (skin tightness, thickening, non-pitting indur-
ation). Minor criteria include: sclerodactyly (only fingers
and/or toes), digital pitting scars or loss of substance of
the digital finger pads (pulp loss), and bibasilar pulmonary
fibrosis.
Our second case fulfils the major criteria of symmetrical
thickening of the skin proximal to the metacarpophalan-
geal joint, as shown in Fig. 6. Our patient also exhibited
Raynaud’s phenomenon, along with other cardinal fea-
tures, which are the most common and earliest mani-
festations of the disease in 95 % of cases, as suggested
by Lester et al. [14] and other authors [6]. Localized
scleroderma/morphea is more common in white women
with a female to male ratio of 2 to 4:1 and an incidence
rate of 0.3 to 3 cases per 100,000 individuals/year.
Fig. 5 Microstomia resulting in difficult prosthesis placement
Fig. 6 Shiny and tense skin of hand showing Raynaud’s
phenomenon and telangiectasia (encircled)
Fig. 7 Hand and Wrist radiograph revealing acro-osteolysis
(encircled) of terminal phalanges of right middle finger
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Morphea (localized scleroderma) causes localized fi-
brosis without systemic involvement and exists in five
different forms but also can persist in “mixed form”
where localized scleroderma of the face can be associated
with plaque morphea or linear scleroderma affecting other
parts of the body, most often the trunk. Linear sclero-
derma, a subtype of morphea, is strongly associated with
Parry–Romberg syndrome (facial hemiatrophy); however,
the relationship is debatable. Linear scleroderma is charac-
terized by unilateral atrophies of the skin, subcutaneous
tissues, muscles, and underlying bone structures with
neurological deficits [8]. Authors have mentioned the co-
existence of en coup de sabre or linear scleroderma with
Parry–Romberg syndrome in 42 % of cases [17]. Tollefson
and Witman [18] have also reported this overlapping of
the two different diseases in 36.6 % of patients. Our
second case was an illustration of the coincidence of
these two diseases. Differential diagnosis of sclero-
derma on the basis of vascular changes can be primary
Raynaud’s phenomenon, physical trauma, chemical ex-
posure, and drugs and/or toxins. On the basis of skin
changes, amyloidosis, insulin-dependent diabetes melli-
tus, metabolic-genetic disorder, and overlap syndrome
can be the differential diagnoses. Ageing, sarcoidosis,
amyloidosis, and autoimmune connective tissue disease
can be considered in the differential diagnosis in cases
of visceral involvement [2].
There are different autoantibodies which are extremely
helpful in forecasting different subtypes of scleroderma.
However, autoantibody absence does not preclude the
diagnosis of this disease as 20 % of the patients with
different subtypes of scleroderma do not show these
antibodies. Highly specific antinuclear antibodies (ANA)
for scleroderma include anti-single-stranded, anti-
histone, and anti-topoisomerase antibodies. Some other
ANA that commonly present in scleroderma include
anticentromere, anti-U3-RNP, anti-Th, anti-fibrillin, anti-
phospholipid, and antimitochondrial antibodies [19–21].
Both of our cases were positive for a few of these sero-
logical markers and the markers were extremely helpful
in yielding a final diagnosis.
Treatment of these types of cases is vastly difficult to
plan as the exact etiology for this disease is not exactly
known. Medical treatments include topical, intralesional,
or systemic glucocorticoids, vitamin E, Vitamin D3,
retinoid, penicillin, griseofulvin, and interferon-alpha.
For those with a more severe and progressive disease,
treatment includes methotrexate (for which there is
limited evidence in linear scleroderma), corticosteroids,
cyclophosphamide, and azathioprine, although it remains
unclear as to how beneficial such treatment modalities
are. Surgical intervention includes restorative plastic sur-
gery (fat or silicone implants, flap/pedicle grafts, or bone
implants) [22, 23].
Preservation or replacement of the existing dentition
is a great challenge for a dentist in these cases. Patients
should be instructed regarding the importance of main-
taining proper oral hygiene and counseled frequently in
order to prevent the patient undergoing depression due
to the challenging nature of the disease. Mouth dilator
exercises such as increasing the number of tongue blades/
ice cream sticks between the posterior teeth, should be en-
couraged. Difficulty in holding a toothbrush secondary to
sclerodactyly can be overcome by advising patients to use
adaptive devices such as electric toothbrushes, Waterpik
flossers, and floss forks. Temporomandibular/myofacial
pain dysfunction can be treated with the use of muscle re-
laxants, physiotherapy, and dental appliances. Dysgeusia
and dental caries secondary to xerostomia can be avoided
by advising the use of artificial saliva, sugar free candies,
fluoride toothpaste and medications like pilocarpine [2].
In severe cases, surgical procedures, such as commissurot-
omy, are recommended to increase mouth opening [24].
Conclusions
With these two case reports we have tried to elucidate
the effects of systemic and localized scleroderma in the
maxillofacial region, as well as discuss systemic manifesta-
tions. Appropriate management of scleroderma requires
frequent consultations with a rheumatologist but general
dentists should monitor patients with scleroderma by
performing frequent clinical and radiological examinations
so as to follow the course of the disease and to meet its
dental challenges.
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